Obtaining global protection for your innovation can be challenging, particularly when considering the different rules and legal systems in the USA and Europe. In this seminar we will explain the post-grant challenges to patents that can be launched in the USA and in Europe, highlighting the opportunities and potential pitfalls within the two legal systems. We will also discuss the Biologics Price Competition and Innovation Act (BPCIA) in the USA and the litigation that has followed. Finally, we will have a panel discussion on the impact of clinical trials on patentability of inventions, addressing the relevance of publication of clinical trial data to assessment of novelty and inventive step in both the USA and in Europe.

Date / Time: July 27 13:30-17:00 | Registration starts from 13:00

Venue:Room 504A, Nangang International Exhibition Center, Hall1 (TaiNEX 1) / No.1, Jingmao 2nd Rd., Nangang District, Taipei City (南港展覽館一館，5樓504A會議室)

Co-organizer: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Registration Link:https://forms.gle/mB3zEc32RYBT7oQy8

Agenda

Speaker's Bio

Amanda K. Murphy
Maeve O'Flynn

Yieyie Yang

Contact:

Laila Liu
Tel: (02)2783-6028ext.25
Email: bioasiataiwan@gmail.com

Due to the high demand for innovations in drug screening, LumiSTAR Biotechnology (Taiwan), HCS Pharma (France), and Molecular Device (USA) co-organized a symposium at BIO Asia-Taiwan 2023 this year, focusing on cutting-edge technologies for high-throughput phenotypic screening.

This session will showcase the revolutionary potential of Human iPSC (induced pluripotent stem cell) technology, advanced 3D culture models, and high-content/high-throughput screening techniques along with state-of-the-art imaging analysis technologies.

Attendees will gain insights into how these advancements are driving accelerated drug discovery. Join us to engage with leading experts and stay at the forefront of the rapidly evolving field of drug screening.

Date / Time: July 27 13:30-17:00

Venue:Room 403, Nangang International Exhibition Center, Hall1 (TaiNEX 1) / No.1, Jingmao 2nd Rd., Nangang District, Taipei City (南港展覽館一館4樓403會議室)

Organizer: LumiSTAR Biotechnology, HCS Pharma, Molecular Devices

Registration Link: https://www.accupass.com/go/drug_screening

Agenda

In this symposium, Baker McKenzie will discuss the focus and trend on digitalization and data and its impact in the healthcare industry, the challenges when healthcare industry incorporates data privacy into compliance programs, and the views about the best practice.  Baker McKenzie will also introduce the key legal and regulatory issues, from the ideation stage to market, that innovators of AI/ML products should consider, as well as the latest cybersecurity trends internationally and share the experiences in Baker McKenzie's leading cases in healthcare sector with key takeaways.

Date / Time: July 28 9:00-12:00/ On-demand

Venue:Room 505A, Nangang International Exhibition Center, Hall1 (TaiNEX 1) / No.1, Jingmao 2nd Rd., Nangang District, Taipei City (南港展覽館一館5樓505A會議室)/ Online event platform

Co-organizer: Baker McKenzie, Taipei (國際通商法律事務所)

Registration Link:https://forms.gle/LhvG88fvxoEdfFGc9

Agenda

Contact:

Laila Liu
Tel: (02)2783-6028ext.25
Email: bioasiataiwan@gmail.com

TBD

TMU x BE x SCHS Demoday: The Next HealthTech Frontier Transforming Hospitals

活動資訊

TMU x BE x SCHS Demoday 即將於台北時間 2023年 7月 29 日星期六上午12時舉辦 Demo Day
實體活動地點：台北南港展覽館1館 4樓401會議室（台北市 11568 南港區經貿二路 1 號）
歡迎對醫療科技與創業投資有興趣的產業相關夥伴一起來共襄盛舉！

Registration Link:https://www.accupass.com/go/TMUxBExSCHS-DemoDay

Agenda

【BE粉專】：https://www.facebook.com/beaccelerator

【北醫生醫加速器粉專】：https://www.facebook.com/tmubiomedaccelerator/

【IRCAD-Taiwan秀傳亞洲遠距微創手術中心粉專】：https://www.facebook.com/ircadtaiwan

With the introduction of information technology, artificial intelligence, 5G, and extensive data analysis in the biomedical industry, Next Generation Sequencing (NGS) technology has become increasingly important. However, the issues of how to build a laboratory quality managment system of genetic testing in Taiwan to connect with global standards, utilize the benefits of big data, promote the clinical benefits of precision medicine, and pave the way for National Health Insurance coverage of NGS need further discussions by key stakeholders..
Using NGS technology to promote precision health has been a shared goal for many nations in recent years, and Taiwan must not fall behind. Taiwan Society of Pathology and PwC Legal Taiwan co-host this symposium to bring together participants from the industry, government, research institutes, and medical field. Join us for this unique opportunity for the advancement of precision medicine in Taiwan.

• Organizer: Taiwan Society of Pathology
• Co-organizer: Taiwan Oncology Society, Taiwan Society of Laboratory Medicine, Precision Medicine Industry Association of Taiwan
• Administrator: PwC Legal Taiwan
• Date and Time: July 29, 2023 (Sat.) 09:00 - 12:05 (Registration start at 08:40)
• Venue: Taipei Nangang Exhibition Center Hall 1, 5F, Room 505 (5F., No. 1, Jingmao 2nd Rd., Nangang Dist., Taipei City 11568)

  COVID疫情催化下，伴隨著科技進化的推波助瀾，改變了醫療服務及醫藥產業的營運模式。在後疫情時代，法規監管機構做為民眾使用藥品的守門員，為確保民眾即時使用到安全、有效、具品質保證之醫藥品，法規規範與管理也進行了大幅度的調整。您想了解美國FDA與歐盟EMA，因應疫情，推行的新法規政策，以及面對這些新的法規規範，生技醫藥產業可能的因應策略與未來趨勢？同時，為回應疫情，數位醫療科技的相助帶來了臨床試驗的轉型，分散式臨床試驗（Decentralized Clinical Trial, DCT）將對未來的醫藥產業、醫療機構及民眾帶來什麼樣的變化？
    台灣醫藥品法規學會非常榮幸邀請到長期深耘國際醫藥產業的王慧君執行長、Linus Kao副總裁，以及食品藥物管理署長官，分享對醫藥品監管法規趨勢的見解，及美、歐、台灣監管機構對DCT的政策措施等。竭誠歡迎對醫藥品法規及臨床試驗議題關切之會員及各界先進踴躍報名參加！
 

主辦單位：台灣醫藥品法規學會
會議時間：2023年7月29日（星期六）下午1點30分
會議地點：亞洲生技大會現場 504A會議室（南港展覽館一館5樓）
報名連結：https://forms.gle/d6FGS6pg2AK5rSox5

Agenda

聯絡人：鍾明翰、譚筱曉，TEL：(02)2747-3625，E-MAIL：tsrap@tsrap.org.tw，更多訊息請參考學會官網 (http://tsrap.org.tw/)